DXC Technology (DXC) Competitors $14.95 -0.33 (-2.16%) As of 02:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DXC vs. RTO, FTAI, CART, ICLR, STN, MEDP, WPP, HQY, BILI, and LYFTShould you be buying DXC Technology stock or one of its competitors? The main competitors of DXC Technology include Rentokil Initial (RTO), FTAI Aviation (FTAI), Maplebear (CART), ICON Public (ICLR), Stantec (STN), Medpace (MEDP), WPP (WPP), HealthEquity (HQY), Bilibili (BILI), and Lyft (LYFT). These companies are all part of the "business services" industry. DXC Technology vs. Rentokil Initial FTAI Aviation Maplebear ICON Public Stantec Medpace WPP HealthEquity Bilibili Lyft DXC Technology (NYSE:DXC) and Rentokil Initial (NYSE:RTO) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership. Do analysts rate DXC or RTO? DXC Technology presently has a consensus target price of $17.80, suggesting a potential upside of 16.42%. Given DXC Technology's higher probable upside, equities analysts clearly believe DXC Technology is more favorable than Rentokil Initial.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DXC Technology 1 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.83Rentokil Initial 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.67 Does the MarketBeat Community favor DXC or RTO? DXC Technology received 406 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 60.71% of users gave DXC Technology an outperform vote while only 33.33% of users gave Rentokil Initial an outperform vote. CompanyUnderperformOutperformDXC TechnologyOutperform Votes41160.71% Underperform Votes26639.29% Rentokil InitialOutperform Votes533.33% Underperform Votes1066.67% Does the media refer more to DXC or RTO? In the previous week, DXC Technology had 30 more articles in the media than Rentokil Initial. MarketBeat recorded 43 mentions for DXC Technology and 13 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 0.98 beat DXC Technology's score of 0.58 indicating that Rentokil Initial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DXC Technology 15 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 8 Negative mention(s) 0 Very Negative mention(s) Positive Rentokil Initial 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, DXC or RTO? DXC Technology has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Is DXC or RTO more profitable? Rentokil Initial has a net margin of 0.00% compared to DXC Technology's net margin of -0.57%. DXC Technology's return on equity of 20.70% beat Rentokil Initial's return on equity.Company Net Margins Return on Equity Return on Assets DXC Technology-0.57% 20.70% 4.87% Rentokil Initial N/A N/A N/A Do insiders & institutionals have more ownership in DXC or RTO? 96.2% of DXC Technology shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 0.5% of DXC Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is DXC or RTO a better dividend stock? DXC Technology pays an annual dividend of $0.84 per share and has a dividend yield of 5.5%. Rentokil Initial pays an annual dividend of $0.68 per share and has a dividend yield of 2.9%. DXC Technology pays out 39.8% of its earnings in the form of a dividend. Rentokil Initial pays out 45.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. DXC Technology is clearly the better dividend stock, given its higher yield and lower payout ratio. Which has stronger valuation & earnings, DXC or RTO? Rentokil Initial has lower revenue, but higher earnings than DXC Technology. DXC Technology is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDXC Technology$12.87B0.22$91M$2.117.25Rentokil Initial$5.44B2.20$473.93M$1.5115.68 SummaryDXC Technology beats Rentokil Initial on 13 of the 21 factors compared between the two stocks. Get DXC Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for DXC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXC vs. The Competition Export to ExcelMetricDXC TechnologyData processing & preparation IndustryComputer SectorNYSE ExchangeMarket Cap$2.77B$4.31B$25.22B$19.70BDividend YieldN/A3.83%2.89%3.84%P/E Ratio-36.4086.1645.0935.13Price / Sales0.221,266.122,227.6934.12Price / Cash1.7933.7434.7817.51Price / Book0.856.456.794.78Net Income$91M$44.05M$737.99M$1.02B7 Day Performance-6.25%-0.23%0.55%1.62%1 Month Performance8.83%28.99%16.30%13.00%1 Year Performance-3.93%19.61%52,512.20%5.59% DXC Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXCDXC Technology3.5048 of 5 stars$14.95-2.2%$17.00+13.7%-5.6%$2.71B$12.87B-35.63130,000Earnings ReportAnalyst ForecastRTORentokil Initial2.0579 of 5 stars$23.04-1.0%N/A-13.9%$11.63B$5.44B15.2562,900FTAIFTAI Aviation4.6603 of 5 stars$112.96+5.4%$171.83+52.1%+49.0%$11.58B$1.91B-1,129.4940Positive NewsCARTMaplebear2.9865 of 5 stars$43.61-0.4%$50.61+16.0%+43.1%$11.45B$3.38B29.273,380Positive NewsAnalyst ForecastGap UpICLRICON Public4.4515 of 5 stars$140.22+4.7%$215.33+53.6%-58.6%$11.32B$8.19B14.7141,100STNStantec2.3729 of 5 stars$93.38-1.0%N/A+27.3%$10.65B$7.50B42.4526,000Trending NewsEarnings ReportDividend IncreaseAnalyst RevisionMEDPMedpace4.7685 of 5 stars$313.74+6.0%$349.30+11.3%-22.8%$9.02B$2.16B24.845,200Positive NewsWPPWPP2.0959 of 5 stars$40.10+1.9%N/A-24.6%$8.65B$14.74B6.72115,500HQYHealthEquity3.2294 of 5 stars$96.66+6.9%$111.75+15.6%+27.4%$8.36B$1.20B88.683,720Positive NewsBILIBilibili2.8499 of 5 stars$18.86+7.6%$21.11+11.9%+12.7%$7.86B$26.83B-41.9112,300Trending NewsUpcoming EarningsAnalyst UpgradeGap UpLYFTLyft3.7922 of 5 stars$17.21+3.4%$16.47-4.3%+2.9%$7.19B$5.79B286.834,420Analyst ForecastHigh Trading Volume Related Companies and Tools Related Companies RTO Alternatives FTAI Alternatives CART Alternatives ICLR Alternatives STN Alternatives MEDP Alternatives WPP Alternatives HQY Alternatives BILI Alternatives LYFT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DXC) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DXC Technology Please log in to your account or sign up in order to add this asset to your watchlist. Share DXC Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.